ExoticRx · exoticrx.com/drugs/lapatinib
Tykerb
Dual tyrosine kinase inhibitor of EGFR (ErbB1) and HER2 (ErbB2). Blocks downstream MAPK and PI3K/Akt signaling. Investigational in canine mammary carcinoma.
Experimental in veterinary oncology. Hepatotoxicity, GI toxicity, and cardiac effects possible. Monitor liver enzymes. Limited veterinary data.
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
Free-tier preview — dog and cat dosing. Pro and Student unlock all 2 species including reptiles, birds, pocket pets, livestock, and equine.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 10–25 mg/kg | q24h | Extrapolated | Papich Handbook of Veterinary Drugs, 5th Ed |
| Cat (Domestic) | PO | 10–25 mg/kg | q24h | Extrapolated | Papich Handbook of Veterinary Drugs, 5th Ed |
Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.